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Inhibition of the DNA-binding activity 
of Drosophila Suppressor of Hairless and 
of its human homolog, KBF2/RBP-JK, by 
direct protein-protein interaction 
with Drosophila Hairless 
Christel Brou/'^ Frederique Logeat,^'^ Magalie Lecourtois,^ Joel Vandekerckhove,^ 
Philippe Kourilsky/ Francois Schweisguth/ and Alain Israel^'^ 
^Unite de Biologic Moleculaire de I'Expression Genique, URA 1149 Centre National de la Recherche Scientifique (CNRS), 
Institut Pasteur, 75724 Paris cedex 15, France; ^Institut Jacques Monod, CNRS Universite Paris VII, 75251 Paris cedex 05, 
France; ^Laboratorium voor Genetica, Rijksuniversiteit Gent, B-9000 Gent, Belgium; '^Unite de Biologic Moleculaire du 
Gene, U. 277 Institut National de la Sante et de la Recherche Medicale (INSERM), Institut Pasteur, 
75724 Paris cedex 15, France 
We have purified the sequence-specific DNA-binding protein KBF2 and cloned the corresponding cDNA, 
which is derived from the previously described RBP-JK gene, the human homolog of the Drosophila 
Suppressor of Hairless [Su(H)] gene. Deletion studies of the RBP-JK and Su(H) proteins allowed us to define a 
DNA-binding domain conserved during evolution. Because Su(H) mutant alleles exhibit dose-sensitive 
interactions with Hairless {H) loss-of-function mutations, we have investigated whether the RBP-JK or Su(H) 
proteins directly interact with the H protein in vitro. We show here that H can inhibit the DNA binding of 
both Su(H) and RBP-JK through direct protein-protein interactions. Consistent with this in vitro inhibitory 
effect, transcriptional activation driven by Su(H) in transfected Drosophila S2 cells is inhibited by H. These 
results support a model in which H acts, at least in part, as a negative regulator of Su(H) activity. This model 
offers a molecular view to the antagonistic activities encoded by the H and Su(H) genes for the control of 
sensory organ cell fates in Drosophila. We further propose that a similar mechanism might occur in 
mammals. 
[Key Words: RBP-JK; KBF2; Su(H); H; protein-protein interaction; transcriptional interaction] 
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The human protein KBF2 specifically binds as a mono­
mer to various KB sites and is present in the nuclei of all 
cells analyzed so far (Israel et al. 1989). We have purified 
this factor and isolated the corresponding cDNA. Data 
base searching revealed a perfect homology with proteins 
belonging to the RBP-JK family. RBP-JK was originally 
purified based on its specific binding to the recombina­
tion signal of the JK immunoglobulin gene (Hamaguchi 
et al. 1989; Matsunami et al. 1989). However, recent data 
strongly suggest that RBP-JK acts as a transcriptional reg­
ulator (Dou et al. 1994) by binding to specific DNA sites, 
whose consensus sequences have been determined (Tun 
et al. 1994), rather than as a recombinase in V(D)f re­
combination (Hamaguchi et al. 1992). 
A better understanding of RBP-JK function may benefit 
^The first two authors contributed equally to this work. 
''Corresponding author. 
from the genetic analysis of the Drosophila RBP-JK ho­
molog Suppressor of Hairless [Su(H)]. The murine RBP-
JK and Drosophila Su(H) proteins share 82% identity and 
94% similarity over most of their length (Furukawa et al. 
1991; Schweisguth and Posakony 1992). Su(H) muta­
tions were first isolated as dominant suppressors of the 
Hairless [H] dominant, haploinsufficient loss-of-func­
tion mutations (Ashbumer 1982). Detailed phenotypical 
studies have shown that H and Su(H) act in an opposite 
maimer to affect various developmental decisions (Bang 
et al. 1991; Bang and Posakony 1992; Schweisguth and 
Posakony 1992, 1994; Posakony 1994). In particular, 
loss-of-function mutations of Su(H) and H have opposite 
effects on two successive alternative cell fate decisions 
during the formation of the adult sense organs. H and 
Su(H) activities are first required in the larva for the 
determination of single sensory organ precursor (SOP) 
cells from groups of equipotent cells called proneural 
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clusters (for review, see Ghysen and Dambly-Chaudiere 
1989). H and Su(H) activities are also required later in 
the development of the pupa to determine the alterna­
tive cell fates adopted by two accessory cells of the 
mechanosensory organs (Bang et al. 1991; Schweisguth 
and Posakony 1994). Each of these two cell fate decisions 
also requires the activity of the neurogenic genes, includ­
ing Notch (for reviews, see Simpson 1990; Posakony 
1994). The role of the H and Su(H) gene products in these 
two NotcA-mediated cell fate decisions remains to be 
elucidated. 
H encodes a novel basic 109-kD protein (Bang and 
Posakony 1992; Maier et al. 1992). The biochemical ac­
tivity and subcellular localization of the H protein are so 
far imknown. The lack of a clear epistatic relationship 
between H and Su(H) for SOP determination has sug­
gested that H and Su(H) act antagonistically in the same 
genetic operation (Schweisguth and Posakony 1994), 
though the molecular mechanism underlying the genetic 
suppression of the H phenotypes by Su(H) mutant alleles 
has not yet been investigated. 
We report here that Su(H) may act as a transcriptional 
activator in a transient transfection assay and that H 
down-regulates transcriptional activation by Su(H) in 
this assay. Negative regulation by H appears to result 
from the formation of H-Su(H) complexes that can pre­
vent the in vitro binding of Su(H) to the DNA. Finally, 
we show that the DNA-binding activity of KBF2/RBP-JK 
can likewise be regulated negatively by Drosophila H 
and that the proteins interact in vitro, as well as in vivo 
using the yeast two-hybrid system. 






RBP4 Exon N l A Exon 2 
ATGCGCAGTGCCGCTCGCGGGCCGCGCCAATCCTGCAGCGCCTTCAACAGGAAA 
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Figure 1. Schematic illustration of the three cloned cDNAs 
resulting from alternative splicing of the 5' exons of the RBP-]K 
gene (exons are represented by boxes) and sequence of the exon 
Nl A of RBP4. Genomic organization of the 5' exons of the gene 
is illustrated at the top (according to Amakawa et al. 1993). 
Numbering indicates exon size in base pairs. 
Results 
Cloning and DNA-binding properties of different 
splicing products of the human RBP-JK gene and 
Drosophila Su(H) 
KBF2 protein was purified from HeLa cells on the basis of 
binding to NF-KB sites, microsequenced, and cloned (see 
Materials and methods for details). Sequencing analysis 
of the obtained cDNA fragment indicated that it encodes 
part of the conserved region of RBP-JK proteins (Ama­
kawa et al. 1993). 
The human RBP-JK gene appears to be composed of 14 
exons (named Nl, 1, 1', N2, and 2-11). Four classes of 
cDNAs, that differ in their first exon but share exons 
2-11, have been described (Amakawa et al. 1993; Dou et 
al. 1994; see Fig. 1). KBF2 could be encoded by any one of 
the four alternatively spliced RBP products already de­
scribed. In this paper the cDNAs and the proteins en­
coded by the aPCRl, aPCR2, and aPCR3 transcripts of 
the RBP-JK gene (Amakawa et al. 1993) are called RBPl, 
RBP2, and RBP3, respectively (see Fig. 1). 
To compare the properties of purified KBF2 to RBPl, 
RBP2, and RBP3, we tried to isolate their corresponding 
cDNAs by PCR amplification. The RBPl and RBP3 cD­
NAs were obtained from a human lymphocyte cDNA 
library. However, we failed to isolate the RBP2 cDNA 
from two different librairies or by reverse transcription-
polymerase chain reaction (RT-PCR) from various 
sources of RNAs (see Materials and methods for details). 
A novel isoform, named RBP4, was isolated from the 
same library and was present in various RNA prepara­
tions (data not shown). Its sequence is shown in Figure 1. 
It differs from RBP2 by the use of an alternative splice 
donor site located within exon Nl (see Amakawa et al. 
1993 for exon nomenclature). 
The DNA-binding activity of KBF2/RBP-JK was exam­
ined using a new putative RBP-binding site found in the 
regulatory region of the mouse Hairy Enhancer of split 
{HESl) gene (Akazawa et al. 1992; Sasai et al. 1992). 
HESl is one of the five mammalian proteins that display 
structural homology with a family of Drosophila bHLH 
proteins encoded by neurogenic genes located in the En­
hancer of split [E(spl)] complex. HESl appears to be in­
volved in neural (Ishibashi et al. 1994) as well as in mus­
cle differentiation (Sasai et al. 1992). Our finding of a 
motif identical to the RBP consensus binding site, 85 bp 
upstream of the transcription initiation site of the HESl 
gene, was guided by the previous description of a strong 
in vitro RBP-binding site in the regulatory region of the 
Drosophila E(spl) m8 gene (Tun et al. 1994). A double-
stranded oligonucleotide corresponding to this putative 
KBF2/RBP-jK-binding site (probe HES) was used in gel 
retardation experiments. We show here that purified 
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Figure 2. DNA-binding properties of the KBF2/RBP 
and Su(H) proteins. [A] The RBP proteins have the 
same DNA-binding specificity as purified KBF2. The 
proteins encoded by the RBPl, RBP3, and RBP4 spHc-
ing products were tested for binding to the HES 
probe: RBP3 (lanes 1,S-10], RBPl (lane 2), and RBP4 
(lane 3) were obtained by in vitro transcription/trans­
lation in a rabbit reticulocyte lysate. Binding of RBP3 
was compared with that of purified KBF2 (lane 4). As 
cold competitor, an excess of 300-fold of probes 2122 
(lane 6), KBF (lane 7), IgK (lane 8), p2m (lane 9), and 
KB2 (lane 10) was used. The arrows indicate the spe­
cific retarded band of each splicing product. [B] Map­
ping of the DNA-binding domain of RBP3. Deletion 
derivatives of RBP3 were obtained by in vitro tran­
scription/translation and tested in a gel shift experi­
ment with the HES probe: RBP3 [1-486] (lane 1), 
RBP3 [1^35] (lane 2), RBP3 [1-329] (lane 3), RBP3 
[1-271] (lane 4), RBP3 [175^86] (lane 5), RBP3 
[7-486] (lane 6), and RBP3 [98-486] (lane 7) (see Fig. 
5A for a schematic representation of these con­
structs). Note that the upper band in lane 2 corre­
sponds to the full-length RBP3 translation product, 
because of an incomplete digestion of the template 
DNA. (C) Mapping of the DNA-binding domain of 
Su(H). Full-length and carboxy-terminal deletion de­
rivatives of the Su(H) protein were produced in vitro 
in a rabbit reticulocyte lysate (lanes 1-S], whereas the 
amino-terminal deletion mutants were analyzed as 
GST fusion proteins (lanes 6-10). In all lanes, the 
2122 probe was used. The relative amount of radio-
actively labeled Su(H) proteins was determined by 
Phosphorlmager quantification following SDS-
PAGE. A similar amount of wild-type and deleted 
Su(H) proteins was used in each lane: Su(H) [10-594| 
(lane 2), Su(H) [10-525] (lane 3), Su(H) [10-457] (lane 
4), Su(H) [10-399] (lane 5). In lanes (^10, - 2 5 0 ng of 
purified GST fusion proteins were assayed: GST-
Su(H) [110-594] (lanes 6,10], GST-Su(H) [139-594] (lane 7), GST-Su(H) [197-594] (lane 8), GST-Su(H) [288-594] (lane 9). As 
a control for specificity, a competition experiment with a 10-fold excess of cold 2122 probe is shown in lane 10. 
^ IP 
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KBF2 protein (Fig. IK, lane 4) and in vitro-translated RBP 
proteins (Fig. IK, lanes 1-3,5-10) strongly bind to the 
HES probe (Fig. 2A). These results suggest that the HESl 
promoter is a potential target for RBP binding. The KBF2 
and RBP proteins also recognize the RBP-JK consensus-
binding site (probe 2122) defined by Tun et al. (1994) 
(data not shown). Both the HES (ttactGTGGGAAa-
gaaagt) and 2122 (gcGTGGGAAc) probes contain the 
core consensus sequence of 7 nucleotides, GTGGGAA, 
that show strong similarities to several NF-KB half-sites, 
including the ^1 microglobulin (p2m) site (aTGG-
GAAagtccct) used in the purification of KBF2. Formation 
of complexes involving either purified KBF2 (Fig. 2A, 
lane 4) or in vitro-translated products (lanes 1-3) can be 
competed by several but not all NF-KB-binding sites, as 
well as by the consensus sequence probe (Fig. 2A, lanes 
5-10; data not shown). These results are consistent with 
data described previously for purified RBP-JK and KBF2 
proteins (Israel et al. 1989; Tun et al. 1994). 
We then compared the relative DNA-binding affinities 
of the three isoforms, RBPl, RBP3, and RBP4, for the 
HES site (Fig. 2A, lanes 1-3). Whereas RBPl and RBP3 
bind with a similar affinity to the HES probe, the RBP4 
product seems to bind this site poorly (equivalent quan­
tities of each translation product were used in each lane). 
This indicates that the isoform-specific amino-terminal 
regions may contribute to RBP DNA-binding specificity. 
The importance of the variable amino-terminal re­
gions in DNA binding was investigated using a deletion 
construct that starts at the first amino acid common to 
all isoforms, the first K residue encoded by exon 2 (see 
Fig. 1) corresponding to amino acid 7 in RBP3 (see Fig. 5, 
below, for a schematic representation of all deletion con­
structs studied). As shown in Figure 2B (lane 6), RBP3 
[7-486] still binds to the HES probe. We conclude that 
the variable amino-terminal regions of RBP are not 
strictly required for DNA binding. Still, the poor binding 
ability of RBP4 suggests that sequences encoded by the 
isoform-specific first exons may modulate the affinity 
and/or specificity of RBP binding to the DNA. 
Further amino-terminal deletions within the protein 
sequence common to all RBP isoforms were also tested 
for their abiUty to bind the HES probe: RBP [98-486] and 
RBP [175-^861 appear unable to bind DNA in our gel 
retardation assay (Fig. 2B, lanes 7 and 5, respectively). 
The effects of carboxy-terminal deletions, introduced in 
the RBP3 cDNA, were also analyzed: The RBP [1-435] 
construct recognized the probe (Fig. 2B, lane 2), whereas 
RBP [1-329] did not (Fig. 2B, lane 3). Thus, the region 
extending from exon 2 (amino acid 7 in RBP3) to amino 
acid 435 appears sufficient for RBP binding to the HES 
probe. 
The Drosophila Su(H) protein was subjected to a sim­
ilar deletion analysis. The nearly full-length in vitro-
translated product (Su(H) [10-594]) binds specifically to 
the RBP consensus-binding site (probe 2122) and more 
weakly to the E(spl) binding site identified by Tun et al. 
(1994) (Fig. 2C, lane 2; data not shown). Whereas the 
truncated Su(H) [10-525] and Su(H) [10-457] proteins 
were still able to bind DNA (Fig. 2C, lanes 3,4), Su(H) 
[10-399] (Fig. 2C, lane 5) did not. Amino-terminal dele­
tions were analyzed as glutathione S-transferase (GST) 
fusion proteins. A fusion protein between GST and Su(H) 
starting at the amino acid position 110 (corresponding to 
amino acid 22 in human RBP3) gave a specific gel-re­
tarded complex (Fig. 2C, lane 6), whereas further dele­
tions starting at amino acid 139 (corresponding to amino 
acid 50 in RBP3) abolished GST-Su(H) DNA binding 
(Fig. 2C, lanes 7-9). Thus, a region extending from amino 
acid positions 110-457 (22-369 in RBP3) appears neces­
sary for Su(H) binding to the 2122 probe. These results 
are summarized in Figure 5A, below. 
Thus, part of the Su(H)/RBP-jK-conserved region, de­
fined as the 425-amino-acid region, which is 82% iden­
tical between the Drosophila and human proteins (Sch-
weisguth and Posakony 1992; see Fig. 5A, below), does 
not appear to be required for DNA binding. One may 
speculate that this carboxy-terminal region [amino acids 
458-528 and 369-439 in Su(H) and RBP3, respectively], 
which has been strongly conserved during evolution, 
provides an interaction surface for molecules other than 
DNA. 
Direct protein-protein interaction between 
Drosophila Su(H) or human RBP3 and Drosophila H 
The H and Su(H) activities have been proposed to act 
antagonistically in the same genetic operation (Schweis-
guth and Posakony 1994). It is thus possible that H and 
Su(H) control common downstream functions in an op­
posite manner. Alternatively, the H and Su(H) proteins 
may interact directly, resulting in the inhibition of ei­
ther H or Su(H) activity. We therefore investigated 
whether the H and Su(H) proteins may interact in vitro. 
First, an Escherichia coli GST-Su(H) fusion protein, 
which contains the conserved region (GST-Su(H) [110-
594]), was tested for its ability to interact with the full-
length H protein synthesized in vitro in a reticulocyte 
lysate (Fig. 3A, lanes 1-3). As shown in Figure 3A, the H 
protein was efficiently retained on GST-Su(H) [110-594] 
(lane 2) but not on control GST beads (lane 3). A number 
of other Drosophila nuclear proteins were tested as con­
trols and were not retained onto the GST-Su(H) [110-
594] beads in this assay [AEF-1 (Falb and Maniatis 1992), 
Daughterless (Gaudy et al. 1988), Groucho (Tata and 
Hartley 1993), Neuralized (Price et al. 1993) (data not 
shown)]. Thus, the H and Su(H) proteins appear to be able 
to specifically interact in vitro under these conditions. 
We then tested various H-deletion constructs for their 
ability to interact in vitro with GST-Su(H) [110-594] 
(Figs. 3A, and 5B for a summary of the results). The first 
293 amino acids appear sufficient to efficiently bind the 
GST-Su(H) [110-594] protein (Fig. 3A, lanes 4-6). In con­
trast, the H [1-236] in vitro translated product did not 
interact with GST-Su(H) [110-594] (Fig. 3A, lanes 7-9). 
This indicates that the H protein contains an interaction 
surface from amino acid 236 to 293, which is required for 
interaction with Su(H). Furthermore, this region is not 
sufficient for the interaction because the H [1-84/236-
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Figure 3. Direct in vitro protein-protein 
interaction between H and Su(H) or RBP3. 
[A] Direct protein-protein interaction be­
tween Su(H) and H. The H [1-1076] and its 
deletion derivatives were in vitro-translated 
in the presence of [^ ^S]Met, and their ability 
to be retained onto a GST-Su(H) [110-594] 
fusion protein or control GST adsorbed to 
glutathione-agarose beads was analyzed by 
SDS-PAGE analysis. Molecular mass mark­
ers (kD) are indicated at the left of each gel 
(10%, 15%, and 20% acrylamide gels are 
shown in lanes 1-6, 7-12, and 13-15, re­
spectively). The input lanes [1,4,7,10,13] 
show the different in vitro-translated prod­
ucts, prior to incubation with the beads. 
The corresponding H constructs are indi­
cated above the lanes (see also Fig. 5B for a 
schematic representation of these con­
structs). The amount of H proteins bound to 
the GST-Su(H) [110-594] beads, shown in 
lanes 2, 5, 8, 11, and 14, is compared with 
the control lanes 3, 6, 9, 12, and 15, which 
correspond with nonspecific binding of the 
same H samples to GST beads. Note that 
identical amounts of in vitro-translated pro­
teins are shown in the input lanes or incu­
bated with the beads. Between 10% and 
25% of the H [1-1076] or H [1-293] fraction 
is reproducibly retained onto the GST-
Su(H) [110-594], compared with the 0.5-1% 
background level on GST beads (lanes 1-6). 
Weaker binding (5-10% of retention) is ob­
served with the H [212-293] construct 
(lanes 13-15], whereas no specific binding is 
detectable with the H [1-236] and [1-84/ 
236-293] constructs (lanes 7-12]. [B] Dele-
" * • » tion mapping of the HID of Su(H). (Lanes 
1-15] Carboxy-terminal truncation deriva­
tives of Su(H) were in vitro-translated in the 
presence of [^ ^S]Met and tested for their interaction with H, using the GST-H [1-292] fusion protein immobilized on glutathione-
agarose beads (see also Fig. 5A). GST is used here as a negative control. Input lanes [1,4,7,10,13] show the different Su(H) in vitro-
translated products, as indicated above the lanes. The fraction of each Su(H) protein retained onto GST-H [1-292] beads is shown in 
lanes 2, 5, 8, 11, and 14, and nonspecific binding of Su(H) proteins to GST beads is indicated in lanes 3, 6, 9, 12, and 15. Between 50% 
and 70% of Su(H) [10-594] or [10-525] is reproducibly retained onto GST-H [1-293] beads (lanes 2,5], compared with the 0.5-2% 
background levels observed with the GST beads alone (lanes 3,6]. No specific binding is detectable for the Su(H) [10-457], [10-399], and 
[10-287] constructs (lanes 7-15]. Molecular mass markers are indicated at the left of the 10% polyacrylamide gel. (Lanes 16-22) 
[^^S]Met-labeled H [1-1076] was tested for its ability to interact with GST-Su(H) fusion proteins corresponding to progressive amino-
terminal deletions (see also D). For each GST-Su(H) fusion protein, the bound fraction (lanes 17-21] was compared with the input (lane 
16] and with the background interaction with GST alone (lane 22]. Molecular mass markers are indicated at the left of the 8% 
polyacrylamide gel. (C) Deletion mapping of the HID of RBP3. [•^ ^S]Met-labeled in vitro-translated derivates of RBP3 (as indicated above 
the lanes) were assayed for their ability to associate with GST-H [1-292] bound to glutathione-agarose beads. Controls were GST alone 
and GST-p50, which is a fusion protein between GST and the p50 subunit of NF-KB, as indicated. Molecular mass markers are 
indicated at the left of the 10% or 12% polyacrylamide gels. Asterisks (*) mark the positions of the in vitro-translated products. 
c 
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293] protein was not retained on GST-Su(H) [110-594] 
beads (Fig. 3A, lanes 10-12). Weak Su(H) binding could 
be detected using the short H [212-293] in vitro-trans­
lated product (Fig. 3A, lanes 13-15), suggesting that this 
region of the H protein contributes in part to the inter­
action with Su(H). 
To map the H interaction domain within Diosophila 
Su(H), we used a bacterially produced GST-H [1-292] 
fusion protein that contains the domain of interaction 
with Su(H) defined above. The nearly full-length in vitro-
translated Su{H) [10-594] protein was specifically and 
efficiently retained by the GST-H [1-292] fusion protein, 
compared with the control GST beads (Fig. 3B, lanes 
1-3). The analysis of carboxy-terminal deletion con­
structs of Su(H) revealed that (1) Su(H) [10-525] still in­
teracts with GST-H [1-292] (Fig. 3B, lanes 4-6), indicat-
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ing that the carboxy-terminal sequences that have not 
been conserved throughout evolution are dispensable for 
interaction with H; and (2) further deletions of conserved 
sequences abolish the in vitro interaction with GST-H 
[1-292] [constructs Su(H) [10-457], Su(H) [10-399], and 
Su(H) [10-287] (Fig. 3B, lanes 7-15; Fig. 5A)]. Amino-
terminal deletion constructs were analyzed using a dif­
ferent experimental strategy: GST-Su(H) fusion proteins 
carrying progressive amino-terminal deletions were 
tested for their ability to retain the H [1-1076] in vitro-
translated product. Negative controls include H binding 
to GST alone (Fig. SB, lane 22) and binding of the Droso-
phila AEFl nuclear protein on these GST-Su(H) beads 
(not shown). Deleting the amino-terminal half of the 
conserved region appears to have no effect on H binding 
in vitro [see the GST-Su(H) [288-594] construct in Fig. 
3B, lane 20]. The GST-Su(H) [444-594] deletion con­
struct, which leaves only 84 amino acids from the con­
served region upstream of the evolutionary divergent 
carboxyl-terminal tail shown above to be dispensable for 
H binding, still exhibits a weak H-binding activity in 
this assay (Fig. 3B, lane 21). Similar results were obtained 
using the H [1-293] in vitro-translated product (not 
shown). We conclude that the H interaction domain 
(HID) is included within the conserved region of Su(H), 
between amino acids 288 and 525 (see Fig. 5A, below). 
The genetic interactions observed between H and 
Su(H) axe thought to unravel a fundamental aspect of 
Su(H) function. Because of the very strong conservation 
of Su(H)/RBP primary structure during evolution, we be­
lieve that both proteins share similar biochemical activ­
ities. We therefore investigated the ability of the RBP3 
isoform to interact with Diosophila H. In vitro-trans­
lated H [1-1076] and H [1-293] interacted with GST-
RBP [1-486] (data not shown), and, conversely, the RBP3 
in vitro-translated protein (RBP3 [1-486]) was retained 
onto the GST-H [1-292] fusion protein bound to gluta­
thione-agarose beads (Fig. 3C, lane 3). This interaction 
appears specific because no significant signal was de­
tected upon binding onto GST or GST-P50, a fusion pro­
tein that consists in the p50 subunit of NF-KB fused to 
GST (Fig. 3C, lanes 1,2). A deletion analysis of RBP3 was 
carried out to independently define the HID. The RBP3 
[1-435] and RBP3 [175-486] mutant proteins were still 
specifically retained onto GST-H [1-292] beads (Fig. 3C, 
lanes 7-9,13-15). This indicates that sequences up­
stream of amino acid 175 and downstream of amino acid 
435 are dispensable for interaction with H in this assay. 
However, the RBP3 [1-329] and RBP3 [1-271] carboxy-
terminal truncated proteins were imable to interact with 
H (Fig. 3C, lanes 10-12, and 4—6, respectively). We then 
assayed a short internal region (RBP3 [330-438]) for its 
capacity to interact with GST-H [1-292]; as shown in 
Figure 3C (lanes 16-18), this 108-amino-acid in vitro-
translated product is specifically retained onto GST-H 
[1-292] beads. Thus, RBP3 can interact in vitro with 
Drosophila H. Both Su(H) and RBP3 interact with a sim­
ilar region of H, located between amino acid positions 1 
and 292 (Figs. 3A and 5B; data not shown). Likewise, a 
similar HID can be defined in both Su(H) and RBP3 pro­
teins (Fig. 5A, below). Note also that the HID partly over­
laps the DNA-binding domain (see Fig. 5A, below). 
In vivo interaction between RBP3 and H in yeast 
RBP3-H protein interaction was then tested in vivo us­
ing the yeast two-hybrid system (Fields and Song 1989; 
Durfee et al. 1993; Harper et al. 1993). Two series of 
expression plasmids were constructed: One encodes seg­
ments of the RBP3 protein fused to the GAL4 DNA-
binding domain [GAL(DB) plasmids in Table 1]; the 
other encodes the GAL4 activation domain, either alone 
[plasmid GAL(AD)] or fused to the first 292 amino acids 
of H (plasmid GAL(AD)-H [1-292]). Each pair of plas­
mids was cotransformed into a yeast strain carrying a 
GAL4 upstream activating sequence {\JAS]-lacZ re­
porter construct integrated into its genome (Harper et al. 
1993). RBP3-H interactions would be expected to medi­
ate the formation of a complex between the GAL(DB)-
RBP3 and GAL(AD)-H [1-292] proteins, resulting in the 
restoration of transcriptional activity. This would be de­
tected as a blue yeast colony because of induced p-galac-
tosidase activity. First, the GAL(DB)-RBP3 fusion con­
structs were not sufficient to induce detectable tran­
scriptional activation of the UAS-lacZ gene when 
cotransformed with GAL(AD), with the exception of the 
GAL(DB)-RBP3 [330-438] fusion protein that gave light 
blue colonies (Table 1). Similarly, the H [1-292] domain 
fused to the GAL4 transcription activation domain did 
not induce lacZ reporter gene transcription when 
cotransformed with the GAL(DB). In contrast, easily de­
tectable lacZ expression was observed when the 
GAL(DB)-RBP3 [1-486], GAL(DB)-RBP3 [175^86], and 
GAL(DB)-RBP3 [330-438] constructs were cotrans­
formed with the GAL(AD)-H [1-292] plasmid. As a neg­
ative control, lacZ expression was not restored when us­
ing GAL(DB)-RBP3 [1-271], in which the HID is deleted. 
Thus, activation of the lacZ reporter gene transcription 
most likely results from specific protein-protein inter-
Table 1. RBP3 and H interact in vivo in yeast 
Fusion proteins 
p-Galactosidase activity 





GAL(DB)-RBP3 [330-438] - / + 
+ + 
-I- -I- - h 
+ + 
Two series of plasmids were constructed, one encoding the 
GAL(DB) fused to various fragments of RBP3 (amino acid num­
bering refers to RBP3), and the other encoding a hybrid of the 
GAL4 activation domain GAL(AD) fused to the first 292 amino 
acids of H (GAL(AD)-H [1-292]). The plasmids were introduced 
into a yeast strain containing the lacZ reporter gene under the 
control of GAL4 elements. p-Gal activity was monitored semi-
quantitatively by the colony lift assay. (-I- -I- -I-) Colonies turned 
blue in <15 min; (-1- -I-) in 15-60 min; (-) colonies remained 
white. 
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action in the yeast nucleus between the HID of RBP3 and 
H [1-292]. These results fully confirm our conclusions 
based on the in vitro study presented in Figures 3 and 5. 
H inhibits the DNA-binding activity of Su(H) 
and RBP proteins 
The antagonistic nature of H and Su(H) activities, to­
gether with the direct protein-protein interaction be­
tween H and Su(H), suggest that H could possibly control 
the activity of Su(H). This could be at the level of DNA 
binding, subcellular localization, or transcriptional ac­
tivity on DNA binding of Su(H). We first examined 
whether the in vitro-translated H protein affects the 
DNA-binding activity of Su(H) (Fig. 4A, lanes 1-7). In­
creasing amounts of H, added to a constant amount of 
Su(H) proteins and DNA probes (Fig. 4A, lane 3; data not 
shown), correlates with a progressive reduction in the 
intensity of the retarded complex. Adding a twofold mo­
lar excess of the H protein, relative to Su(H), decreases 
the amount of the retarded complex by about threefold 
(data not shown). H alone did not bind to the 2122 nor 
HES probes (Fig. 4A, lanes 1,11; data not shown), and the 
formation of new, supershifted complexes was not ob­
served. Thus protein-protein interactions between H 
and Su(H) apparently lead to the formation of complexes 
that are unable to recognize the Su(H) target site. The 
specificity of this inhibitory effect could be demon­
strated further using two Su(H) truncated proteins. Su(H) 
[10-525] was shown to both bind DNA (Fig. 2C, lane 3) 
and interact in vitro with H (Fig. 3B, lane 5). Consistent 
with these data, we show here that H inhibits the DNA 
binding of Su(H) [10-525] (Fig. 4A, lanes 4,5). In contrast, 
Su(H) [10-457] is known to bind DNA but not H (Fig. 2C, 
lane 4; Fig. 3B, lane 8; Fig. 5A, below): Accordingly, H 
had no detectable effect on its DNA-binding ability (Fig. 
4A, lanes 6,7]. This result confirms that a region between 
amino acids 457 and 525 in Su(H) is necessary for inter­
action with H but not for DNA binding (Fig. 5A). We 
then investigated whether Diosophila H may also in­
hibit KBF2/RBP-JK DNA-binding activity. As shown in 
Figure 4A, H effectively decreases binding of purified 
KBF2 (Fig. 4A, lanes 8,9), as well as of the in vitro-trans­
lated proteins RBP 1 (lanes 13,14), RBP3 (lanes 10,12), and 
RBP4 (data not shown), to the HES probe. A similar in­
hibitory effect was also observed with recombinant 
GST-RBP3 fusion protein (Fig. 4B, cf. lanes 11 and 7) or 
with the endogenous KBF2 activity present in nuclear 
extracts from several cell lines (human kidney 293T and 
neuroblastoma NGP, mouse myoblast C2; data not 
shown). As a negative control we verified that H does not 
affect the DNA-binding activity of the p50 subunit of 
NF-KB (data not shown). Finally, several H-deletion mu­
tants were tested for their capacity to inhibit Su(H) or 
RBP3 DNA-binding activity. A similar fivefold molar ex­
cess of H proteins relative to Su(H) was used for all H-de­
letion constructs (Fig. 4B, lanes 1-6). The amount of H 
proteins compared with bacterially produced GST-RBP3 
proteins was kept constant in all lanes (Fig. 4B, lanes 
7-11). Full-length H and H [1-710] exhibited strong 
v^ .CV .C< ^^ <s^ ' # 
H - h - - l - - + - - l - - + - + + + -
1 2 3 4 5 6 7 8 9 10 11 12 13 14 







. ^^ i^^ >;^ ^ ^^ % v^^ '. 
1 2 3 4 5 6 7 8 9 10 11 
Figure 4. H inhibits the DNA-binding activity of Su(H), KBF2, 
and RBP isoforms. [A] A fivefold molar excess of in vitro-trans­
lated H (lanes 1,3,5,7,9,11,12,13) or unprogrammed rabbit retic­
ulocyte lysate (lanes 2,4,6,8,10,14] was preincubated with in 
vitro-translated Su(H) (lanes 2,3), Su(H) [10-525] (lanes 4,5], 
Su(H) [10-457] (lanes 6,7], RBP3 (lanes 10,12], RBPl (lanes 
13,14), or purified KBF2 (lanes 8,9) before addition of 2122 (lanes 
1-7] or HES probe (lanes 8-14] and assayed by gel shift. (5) 
Deletion mapping of the H region required to inhibit the bind­
ing of Su(H) to the 2122 probe (lanes 1-6) or of recombinant 
GST-RBP3 to the HES probe (lanes 7-12). Identical amounts of 
in vitro-translated H (lanes 2,7], H [1-710] (lane 8), H [1-293] 
(lanes 3,9], H [1-236] (lanes 4,10], H [1-84/236-293] (lane 5), H 
[212-293] (lane 6), or unprogrammed lysate (lanes 1,11] were 
incubated with Su(H) or GST-RBP3 as indicated, before addi­
tion of probes 2122 (lanes 1-6] or HES (lanes 7-11). 
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Figure 5. Schematic representation of the 
functional domains of the Su(H), RBP3, and 
H proteins. (A) Deletion mapping of Su(H) 
[top] and RBP3 {bottom) DNA-binding do­
main and HID. Su(H) and RBP3 are drawn at 
the same scale and are aligned following 
their highly conserved region represented as 
a solid box [Su(H), amino acids 103-528; 
RBP3, amino acids 15-440]. The results of 
the gel shift experiments of Fig. 2, B and C, 
are summarized in the column labeled DNA 
binding ( + , DNA binding; - , no DNA 
binding), the results of the in vitro interac­
tion experiments of Fig. 3 in the column la­
beled in vitro interaction with H (+, inter­
action with H; - , no detectable interaction; 
+ / -, weak interaction; ns, not shown; nd, 
not determined), the results of gel shift ex­
periments of Fig. 4 in the column labeled 
inhibition of DNA binding by H (-I-, H in­
hibits the DNA binding of this protein; —, 
H has no effect on DNA binding). In the 
central part, the DNA-binding domain and 
the HID of Su(H) and RBP3 are compared. 
[B] Deletion mapping of the H protein. The 
results presented in Figs. 3 and 4 are sum­
marized here as in A. 
DNA-binding inhibition activity, whereas H [1-293] 
gave a weaker inhibitory effect (Fig. 4B lanes 2,3,7-9). 
The H [1-236], H [1-84/236-293], and H [212-293] mu­
tant proteins had no inhibitory effects upon Su(H) DNA 
binding (Fig. 4B, lanes 4-6,10). These results, summa­
rized in Figure 5B, are all consistent with the in vitro 
protein interaction results (Figs. 3A and 5B), with the 
exception of the H [212-293], which was able to weakly 
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interact in vitro with GST-Su(Hj [110-594] but did not 
inhibit Su(H) DNA-binding activity or supershift the re­
tarded complex. 
H inhibits Su(H}-dependent transcriptional 
activation in transfected S2 cells 
The importance for transcription regulation of the inhi­
bition by H of the Su(H) DNA-binding activity was ex­
amined in cotransfection experiments using the Droso-
phila cell line S2 (Fig. 6). Two direct repeats of the 2122 
DNA-binding sites were introduced upstream of the 
minimal Adh promoter [ - 86, + 53] (England et al. 1990) 
driving CAT gene expression [(2122)2Adh-86 CAT]. CAT 
activity was measured following cotransfection of the 
above with expression plasmids producing the Su(H) 
and/or H gene products under the control of the actin 5C 
promoter. 
First, although no effect was observed using the Adh-
86 CAT reporter plasmid alone, CAT expression from 
the (2122)2Adh-86 CAT construct was increased upon 
cotransfection with Su(H). Average stimulation was 
found to be 7.4-fold, indicating that Su(H) acts as a tran­
scriptional activator in this assay. Second, cotransfection 
of the Su(H) and H expression vectors resulted in a dose-
dependent reduction of the stimulated CAT expression. 









Figure 6. Transcriptional activities of Su(H) and H in Droso-
phila S2 cells. CAT assays of S2 cell extracts following trans-
fection with 2 |xg of the reporter genes Adh-86 CAT (open bars) 
or (2122)2Adh-86 CAT (shaded bars) along with variable 
amounts of the Su(H) and/or H expression vectors as indicated. 
Histograms correspond to the average of at least three indepen­
dent experiments. Each activity is compared with that of 
(2122)2ADH-86 taken as 1. Values corresponding to each bar are 
as follows: 0.3; 1; 0.4; 7.4; 2.9; 0.25; 1.8; 0.2; 1.4. 
H/Su(H) ratio of 1:1, and 1.8-fold with a 4:1 ratio. As a 
control, H did not, on its own, affect the level of expres­
sion of the two reporter genes used. These results indi­
cate that H may inhibit in vivo the transcriptional acti­
vation of a synthetic promoter mediated by Su(H). 
Discussion 
We report here the cloning of a cDNA encoding the KBF2 
protein. Peptide and cDNA sequencing revealed that 
KBF2 is identical to RBP-JK (Matsunami et al. 1989; 
Amakawa et al. 1993). The genomic organization of the 
human RBP-JK gene has been reported (Amakawa et al. 
1993). Three different spHcing products, RBPl, RBP2, 
and RBP3 (according to the nomenclature proposed in 
this paper), have been described by Amakawa et al. 
(1993). We describe here a fourth isoform, RBP4, that 
contains part of exon Nl linked to exon 2. A fifth protein 
that corresponds to the previously described mouse 
splicing product RBP2N (Kawaichi et al. 1992) was re­
ported recently (Dou et al. 1994). It is possible that other 
potential splicing products may exist. The purified KBF2 
activity may thus correspond to a single splicing product 
or a combination of specific RBP splicing products. The 
DNA-binding domain of RBP maps to a large, highly con­
served region common to all isoforms [from amino acid 
7 to 435 in RBP3, and from 110 to 457 in Su(H)]. The 
possible functional diversity associated with these vari­
ous RBP isoforms remains to be investigated. Similarly, 
although the RBP-JK gene products are expressed in 
many different cell types (Hamaguchi et al. 1992; data 
not shown), the detailed expression pattern of each iso­
form has not been described and awaits the use of iso-
form-specific probes. 
Direct protein-protein interaction with Drosophila 
H prevents Su(H)/RBP3 binding to DNA 
Further insights into the possible regulation of RBP ac­
tivity were gained from studies of Su(H) function in fly 
development. Su(H), together with H, controls at least 
two alternative cell fate decisions during peripheral ner­
vous system (PNS) formation of the adult fly (Bang et al. 
1991; Bang and Posakony 1992; Schweisguth and Posa-
kony 1992, 1994). We show here that Su(H) binds the 
consensus-binding site defined for the mouse RBP pro­
tein and acts upon transfection as a transcriptional acti­
vator of an artificial promoter carrying two copies of this 
sequence. These two assays for Su(H) function allowed 
us to investigate the molecular basis of the antagonistic 
activity of the H protein, for which no biochemical ac­
tivity is known so far. First, H acts as a repressor by 
decreasing in a dose-dependent manner the transcrip­
tional activation mediated by Su(H) in transfected cells. 
We show further that H specifically prevents Su(H) bind­
ing to its target site in vitro and that H interacts directly 
with Su(H) in vitro. The ability of H to inhibit Su(H) 
DNA binding extends to its vertebrate cognates, RBPl, 
RBP3, and RBP4, as well as to purified KBF2. Likewise, H 
and RBP3 were shown to interact in vivo using the yeast 
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two-hybrid system and in vitro by direct protein-protein 
interactions. The functional domain required for inter­
action with H (HID) Hes within the region highly con­
served between Su(H) and RBP-JK. The HID displays a 
high percentage of prolines (10%) and hydrophobic 
amino acids (28% for RBP3 [330-438] and 26% for the 
corresponding region of Su(H) [419-527]). We note that 
the H domain required for the interaction with Su{H) 
also includes a potential a-helix [223-247] with hydro­
phobic residues on one side of the helix. The role of these 
hydrophobic residues in the formation of H-Su(H) com­
plexes remains to be investigated. The PRD repeat lo­
cated at the carboxy-terminal end of the H protein, 
which may regulate protein-protein interactions (Jan-
knecht et al. 1991), plays no apparent role in the H-Su(H) 
interaction. 
The mechanism by which H prevents Su(H)/RBP 
DNA binding is at unclear present. Considering that the 
HID partly overlaps the Su(H)/RBP3 DNA-binding do­
main, it is possible that H partly masks the DNA inter­
action surface of Su(H) and RBP. H and Su(H)/RBP would 
then form stable complexes unable to bind DNA. This 
hypothesis is reminiscent of the mechanism by which 
calreticulin prevents the glucocorticoid receptor from 
binding to its DNA response element (Burns et al. 1994; 
Dedhar et al. 1994) or IPl inhibits API DNA binding 
(Auwerx and Sassone-Corsi 1991). An altemative mech­
anism that cannot be formally excluded is one in which 
the H-Su(H)/RBP complex could still bind DNA but 
with an altered specificity. 
Could the formation of H-Su(H) heteromeric 
complexes account for the antagonistic genetical 
interactions observed between H and Su(H)l 
The results described in this paper would fully support a 
model in which H acts as a negative regulator of Su(H) 
activity. However, the dose-sensitive genetic interac­
tions associated with partial loss of function in these two 
genes initially led Ashbumer (1982) to propose that 
Su(H) acts as a negative regulator of H function. This 
conclusion stems from the observation that a reduction 
in Su(H) gene dosage suppresses the partial H loss-of-
function phenotype, whereas an increase in gene dosage 
enhances it (Ashburner 1982). However, as first pointed 
out by Locke et al. (1988), these dose-dependent effects 
could also be explained by the formation of multiprotein 
complexes involving the Su(H) protein. We thus propose 
that Su(H) acts on DNA binding to favor the adoption of 
an epithelial, that is, epidermal and socket-producing, 
cell fate and that H inhibits its DNA-binding activity to 
promote a subepithelial, that is, neuronal and shaft-se­
creting, cell fate. This proposal is entirely consistent 
with a role for H in protecting the future SOP cell from 
residual negative signaling that would be mediated by 
Su(H) (Bang and Posakony 1992). The observation that 
the neurogenic Su(H) null phenotype is partially sup­
pressed in Su(H);H double mutant larvae (Schweisguth 
and Posakony 1994) may also suggest that H acts inde­
pendently of Su(H) to negatively regulate additional neu­
rogenic activities. Thus, it is possible that H, when not 
associated with Su(H), may still participate in other reg­
ulatory interactions. We propose that direct protein-pro­
tein interactions between H and Su(H) control both the 
activity of Su(H) and the amount of H protein unbound 
to Su(H). The dominant loss of H function phenotype 
predicts that H is present in limiting amount. A three­
fold increase in Su(H) gene dosage results in an adult 
phenotype very similar to the dominant H phenotype 
observed in H heterozygote flies (Schweisguth and Posa­
kony 1994; data not shown). Although the subcellular 
distribution of the H protein is not yet known, the nu­
clear localization of both Su(H) (F. Schweisguth, M. Le-
courtois, and J.W. Posakony, unpubl.) and RBP (Hamagu-
chi et al. 1992) suggests that the H-Su(H) complex prob­
ably forms in the nucleus. 
Functional conservation between Su(H) and RBP-K 
Our results suggest a possible interpretation for the re­
markable degree of structural similarity between Su(H) 
and RBP. First, these proteins have a large DNA-binding 
domain. Second, the highly conserved sequences that are 
not required for DNA binding appear involved in pro­
tein-protein interactions. Considering that regulation by 
H is a fundamental aspect of Su(H) activity in flies and 
that the human RBP proteins interact with Drosophila H 
in a manner identical to Su(H), we propose that a human 
H homolog should exist that has the same ability to in­
teract with the RBP proteins. Experiments are in prog­
ress to isolate this human homolog of H. This study also 
suggests another level of functional conservation be­
tween Su(H) and RBP. Genes from the E(spl) complex are 
thought to act at the last step in a genetic cascade of gene 
activities restricting neural fate and to be the genetic 
target of the H gene activity (de la Concha et al. 1988). 
Consistent with this proposition, the promoter of the m8 
gene of the E(spl) complex contains a potential binding 
site for Su(H) (Tun et al. 1994; M. Lecourtois and F. Sch­
weisguth, unpubl.). We further report here that the pro­
moter of the HESl gene, a mammalian homolog of the 
E(spl) genes, also contains a strong RBP-binding site. 
This raises the exciting possibility that not only the 
specificity of DNA binding and the negative regulation 
by H, but also their direct downstream target genes have 
been conserved throughout evolution. Whether RBP-JK 
may also act as Su(H) in the Notch-mediated signaling 
pathway during mammalian development remains to be 
determined. 
Materials and methods 
Purification and cloning of KBF2 
KBF2 was purified from 250 grains of HeLa cells. Its activity was 
followed by bandshift assay as described in Israel et al. (1989). 
Nuclear extract preparation, ammonium sulfate precipitation, 
and hydroxylapatite chromatography have been described in Ki-
eran et al. (1990). The fraction eluted from the hydroxylapatite 
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column, which contains both KBFl and KBF2, was dialyzed 
against a buffer containing 0 . 1 M NaCl and then loaded onto a 
DNA affinity column containing the H-2K'' KB site in the pres­
ence of poly[d(I-C)j (Kieran et al. 1990). This step allowed sep­
aration of KBFl, retained onto the affinity column, from KBF2 
that does not bind to the H-2K'' KB site under the conditions 
used. The flowthrough was subsequently loaded onto a heparin-
agarose column. KBF2 activity was eluted at 0.3 M NaCl, dia­
lyzed, and loaded onto a sulfopropyl ion-exchange column. Ac­
tive fractions eluting at 0.6 M NaCl were pooled and dialyzed 
against a buffer containing 50 mM NaCl. A second DNA affinity 
column containing the p2m site (Israel et al. 1989) was then 
used. Most of the KBF2 activity bound to this column, and the 
KBF2 protein was eluted at 0.2 M NaCl. The active fraction was 
dialyzed and loaded once again onto the p2m affinity column. 
SDS gel analysis detected a single 58-kD protein. This 58-kD 
protein could be specifically cross-linked by UV irradiation to 
the p2m oligonucleotide (Israel et al. 1989). The purified protein 
fraction (15 \x,g) was dialyzed against 10 mM ammonium acetate 
(pH 6.0), 0.02% SDS, and lyophilized. Tryptic peptides were 
prepared. Three of the seven purified peptides (peptides 8, 9, and 
14) were sequenced as described in Kieran et al. (1990). 
The sequences of the peptides are peptide 8, QTALLDAD-
DPVSQLH; peptide 9, QPVQVPVTLVR; and peptide 14, V?F-
GDVEAET/DMY. Degenerated oligonucleotides deduced from 
the sequence of peptides 8 and 14 (primer 8^, CAGACAGCCC-
TGCTGAATGCTGATGACCCTGTCTCCCAGCTGCA; and 
primer 14", AAACCICTACAICTCCGICT) were synthetized 
and used as primers in polymerase chain reactions (PCRs), using 
a Xgt 10 library derived from the human T47D carcinoma as 
template (gift of H. Loosfelt, Kremlin Bicetre, France). PCR con­
ditions were as follows: 1 min at 94°C, 1 min at 50°C, and 1 min 
at 72°C, for 30 cycles. The DNA fragment obtained after ampli­
fication was cloned into pBluescript (Stratagene). This fragment 
was used to screen 2x10^ plaques from the same Xgt 10 cDNA 
library. A 1.3-kb cDNA was isolated and subcloned into pBlue­
script. Sequencing was done on both strands using the dideoxy 
technique. The sequence encoded by the largest open reading 
frame contained peptides 8, 9, and 14 and corresponded to 
amino acids 16-449 of the aPCR3 splice product of RBP-JK 
(Amakawa et al. 1993). 
Isolation of the isoform-specific RBP cDNAs 
Three oligonucleotides—5' -cgtggatccATGGACC ACACGGA-
GGGCTTG-3', 5'-cgtggatccATGCGCAGTGCCGCTCGCGGG-
3', and 5'-cgtggatccGCATGGATTAAAAGGAAA-3'—that cor­
respond to the 5' ends of the human RBPl, RBP2, and RBP3 
isoforms, respectively (Amakawa et al. 1993), were used in PCR 
experiments in combination with a common oligonucleotide, 
5'-cgcggatccTTAGGATACCACTGTTGGTGTAGA, whose se­
quence is derived from exon 11. BamHl sites were introduced at 
the 5' end of the primers. PCR experiments were carried out 
using either the same human T47D carcinoma library as above 
or a human lymphocyte cDNA library (gift of S. Elledge, How­
ard Hughes Medical Institute, Houston, TX). In both cases, the 
same two amplification products were obtained under standard 
conditions. Following subcloning at the BamHl site of pT7(3link 
(Pollock and Treisman 1991) and sequencing analysis, we con­
firmed the presence of full-length cDNA clones encoding RBPl 
and RBP3 in these libraries. 
In a further attempt to isolate a RBP2 cDNA, poly(A)+ RNAs 
from HeLa, Daudi, K562, and T47D cell lines were subjected to 
reverse transcription using an oligo(dT) primer with the MuLV 
transcriptase, followed by PCR amplification. In all cases, a 1.5-
kb fragment was obtained, although the expected size for the 
RBP2 cDNA is 1.6 kb. The HeLa RT-PCR product was sub-
cloned and sequenced: It corresponds to RBP4 (see Fig. 1). 
Synthesis of in vitio-tianslated products and bandshift assays 
In vitro-translated proteins were all synthesized in a reticulo­
cyte lysate-coupled transcription/translation system (Promega), 
from cDNA fragments inserted into the pT7plink vector. The 
cDNA fragment encoding the first 293 amino acids of H was 
subcloned following PCR amplification, using a composite full-
length cDNA clone as template (plasmid KH, a gift from A. 
Preiss, Biozentrum, Basel, Switzerland) (Maier et al. 1993). The 
full-length H was obtained by inserting an £coRI fragment pu­
rified from plasmid KH into the unique £coRI site of pT73linkH 
[1-293]. The amino-terminal deletion mutants RBP3 [175-486], 
RBP3 [7-486], RBP3 [98-486], and RBP3 [1-271] were obtained 
by PCR amplification from a template containing the full-
length RBP3 cDNA. The carboxy-terminal deletion mutants 
RBP3 [1-435], RBP3 [1-329], and H [1-710] were obtained by 
digestion with restriction enzymes Sad, Apal, and Xhol, respec­
tively, of the corresponding pT7plink constructs. The carboxy-
terminal deletion mutants SujH) |10-525], Su{H) (10-457], Su(H) 
[10-399], and Su(H) [10-287] were obtained from internal dele­
tions of the pT73link Su(H) [10-594] construct, using the re­
striction enzymes Eagl-Xbal, Pstl, Nail-Smal, and HincII-
Smal, respectively. The following H constructs—H [1-236], H 
[212-293], and H [1-84/236-293]—were generated by internal 
deletions of the pT7phnk H [1-293], using the Dral-EcoRl, 
Ncol-Hindlll, and Notl-Dial restriction enzymes. 
Bandshift assays were performed as described in Israel et al. 
(1989) and Antoniewski et al. (1994). The following double-












CACCCTTTGGGTCCtag-5' (Le Bail et al. 1993) 
GST fusion proteins and interaction assays 
For GST-RBP3 protein expression in E. coh, a restriction frag­
ment from pT7(3link RBP3 construct was subcloned into the 
pGEX-KT vector as a fusion with GST (Smith and Johnson 1988; 
Hakes and Dixon 1992). The amino-terminal deletion deriva­
tives of Su(H) were obtained by subcloning the Ncol-Ndel, 
Xmnl-Ndel, Scal-Ndel, Hincll-Ndel, and Mscl-Ndel cDNA 
fragments purified from KS12 (Schweisguth and Posakony 1992) 
into the filled-in BamHl site of the pGEX-KG vector (Hakes and 
Dixon 1992). 
The in vitro-translated proteins (3 |xl) were mixed with glu­
tathione-agarose beads (10 \il) coated with GST protein and 
preadsorbed for 1 hr at 4°C in buffer A (40 mM HEPES at pH 7.5, 
5 mM MgClj, 0.2 mM EDTA, 1 mM DTT, 0.5% NP-40, 100 mM 
KCl). The supernatant was incubated with glutathione-agarose 
beads carrying either GST or GST fusion proteins (RBP3, Su(H), 
or H [1-293]) for 1 hr at 4°C. The beads were washed extensively 
with buffer A, then with buffer A containing 200 mM KCl. As­
sociated proteins were eluted by boiling in Laemmli buffer and 
subjected to SDS-PAGE analysis, followed by fluorography. 
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Yeast two-hybiid system 
Y190 strain (Harper et al. 1993) contains a GAL-lacZ reporter 
integrated into the genome. Its genotype is [MATa, leu2-3,112, 
uia3-52, trpl-901, his3-D200, ade2-101, gaUA galSOA URA3:: 
GAL-lacZ, LYS::GAl^HIS3, cyh']. The pASl-CYH2-derived 
plasmids contain the first 147 amino acids of GAL4, which 
correspond to its DNA-binding domain [GAL(DB)] fused to var­
ious fragments of RBP3, obtained by Ncol and Xhol digestion of 
the pTZplink-derived vectors and insertion at the Ncol and Sail 
sites of pASl-CYH2. The GAL(AD)-H [1-292] encodes the ac­
tivation domain of GAL4 [plasmid pACTlI (Durfee et al. 1993)] 
fused to the amino-terminal 292 amino acids of H. The 
pT7pIink-H plasmid was digested by Xbal, filled-in by the Kle-
now enzyme, and redigested by Ncol. The appropriate fragment 
was inserted into pACTII vector digested by Ncol and Smal. 
Y190 was transformed by the pACTlI- and PASl-derived plas­
mids using the lithium acetate method (Gietz et al. 1992). The 
transformants were selected on Ura^Leu'Trp" glucose plates 
and tested for p-galactosidase activity using a filter-lift assay 
(Breeden and Nasmyth 1985). Colonies were transferred onto 
nitrocellulose filters, permeabilized by freezing in liquid nitro­
gen, and thawed at room temperature. Filters were then overlaid 
on Whatman 3MM paper saturated with an X-gal solution 
(Breeden and Nasmyth 1985) and incubated at 30°C. The time 
required for color development ranged from 10 min to 2 hr. 
Cell transfections and CAT assays 
Drosophila Schneider S2 cells were maintained at 25°C in 
Schneider medium (GIBCO) supplemented with 5% fetal calf 
serum and 50 M-g/nil of penicillin and streptomycin. Cells were 
transfected using the calcium phosphate coprecipitation tech­
nique, at 50% confluence in 5-cm plates. Two micrograms of 
reporter plasmid, different amounts of expression vectors as de­
scribed in Figure 5, and empty pPac2 expression vector as a 
carrier, up to a total of 5 |xg, were used for each plate. Transfec-
tion efficiency was evaluated by cotransfecting 100 ng oihsp82-
lacZ (Dorsett et al. 1989). The {Xhol-Xbal) Su(H) and {Kpnl-
Xbal] H cDNA fragments were subcloned between the Xhol or 
Kpnl, and Xbal sites, respectively, of the expression vector plas­
mid pPac2 (a gift of L. Ruel and M. Bourouis, Laboratoire de 
Genetique Moleculaire des Eucaryotes, Strasbourg, France). A 
direct repeat of the 2122 oligonucleotide was inserted at the 
BamHl site upstream of the minimal Adh [ - 86, + 53] promoter 
to create (2122)2Adh-86 CAT (England et al. 1990). Twenty-four 
hours after transfection, cells were harvested and lysed in 60 ml 
of buffer containing 25 mM Tris-phosphate (pH 7.8), 8 mM 
MgClj, 1 mM DTT, 1% Triton X-100, and 15% glycerol. An 
appropriate amount of extract was incubated in a final volume 
of 50 |xl of Tris (250 mM at pH 7.5) for 10 min at 70°C, and added 
directly to 200 |xl of the reaction mixture [1.25 mM chloram­
phenicol, 0.5 jJiCi of ^H-labeled acetyl CoA (3.6 Ci/mM), 125 
mM Tris at pH 7.5), and 3 ml of Econofluor 2 (NEN DuPont). 
The linearity of the reaction was verified by counting samples at 
regular intervals. 
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